289 related articles for article (PubMed ID: 8276238)
1. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
Pavletich NP; Chambers KA; Pabo CO
Genes Dev; 1993 Dec; 7(12B):2556-64. PubMed ID: 8276238
[TBL] [Abstract][Full Text] [Related]
2. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
Cho Y; Gorina S; Jeffrey PD; Pavletich NP
Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
5. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
[TBL] [Abstract][Full Text] [Related]
6. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
Gorina S; Pavletich NP
Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
[TBL] [Abstract][Full Text] [Related]
7. p53 domains: identification and characterization of two autonomous DNA-binding regions.
Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
[TBL] [Abstract][Full Text] [Related]
8. Structure of the p53 core domain dimer bound to DNA.
Ho WC; Fitzgerald MX; Marmorstein R
J Biol Chem; 2006 Jul; 281(29):20494-502. PubMed ID: 16717092
[TBL] [Abstract][Full Text] [Related]
9. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
10. Sequence-specific interaction of a conformational domain of p53 with DNA.
Srinivasan R; Roth JA; Maxwell SA
Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
[TBL] [Abstract][Full Text] [Related]
11. The role of tetramerization in p53 function.
Chène P
Oncogene; 2001 May; 20(21):2611-7. PubMed ID: 11420672
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
[TBL] [Abstract][Full Text] [Related]
13. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
Srinivasan R; Maxwell SA
Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
15. Common conformational effects of p53 mutations.
Chen JM; Rosal R; Smith S; Pincus MR; Brandt-Rauf PW
J Protein Chem; 2001 Feb; 20(2):101-5. PubMed ID: 11563689
[TBL] [Abstract][Full Text] [Related]
16. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.
Bayle JH; Elenbaas B; Levine AJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5729-33. PubMed ID: 7777576
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domain.
Ouaray Z; ElSawy KM; Lane DP; Essex JW; Verma C
Proteins; 2016 Oct; 84(10):1443-61. PubMed ID: 27317883
[TBL] [Abstract][Full Text] [Related]
18. Target gene modulation in hepatocellular carcinomas by decreased DNA-binding of p53 mutations.
Kubicka S; Trautwein C; Niehof M; Manns M
Hepatology; 1997 Apr; 25(4):867-73. PubMed ID: 9096590
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
Luciani MG; Hutchins JR; Zheleva D; Hupp TR
J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
[TBL] [Abstract][Full Text] [Related]
20. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
